HK1086562A1 - Pyrazoloquinolines with immunomodulating activity - Google Patents

Pyrazoloquinolines with immunomodulating activity

Info

Publication number
HK1086562A1
HK1086562A1 HK06106518A HK06106518A HK1086562A1 HK 1086562 A1 HK1086562 A1 HK 1086562A1 HK 06106518 A HK06106518 A HK 06106518A HK 06106518 A HK06106518 A HK 06106518A HK 1086562 A1 HK1086562 A1 HK 1086562A1
Authority
HK
Hong Kong
Prior art keywords
pyrazoloquinolines
methods
heterocyclic compounds
relates
present
Prior art date
Application number
HK06106518A
Other languages
English (en)
Inventor
Ian Richard Matthews
Thomas Stephen Coulter
Chiara Ghiron
Chris James Brennan
Muhammed Kamal Uddin
Lars Olof Goran Pettersson
Dorthe Da Graca Thrige
Philip Huxley
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0203471A external-priority patent/SE0203471D0/xx
Priority claimed from SE0301299A external-priority patent/SE0301299D0/xx
Priority claimed from SE0301851A external-priority patent/SE0301851D0/xx
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of HK1086562A1 publication Critical patent/HK1086562A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK06106518A 2002-11-22 2006-06-07 Pyrazoloquinolines with immunomodulating activity HK1086562A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US42824002P 2002-11-22 2002-11-22
SE0203471A SE0203471D0 (sv) 2002-11-22 2002-11-22 Immunomodulatory compunds
SE0301299A SE0301299D0 (sv) 2003-05-06 2003-05-06 Immunomodulatory compounds
US48212203P 2003-06-25 2003-06-25
SE0301851A SE0301851D0 (sv) 2003-06-25 2003-06-25 Immunomodulatory compounds
PCT/SE2003/001805 WO2004048378A1 (fr) 2002-11-22 2003-11-21 Pyrazoloquinolines a activite immunomodulatrice

Publications (1)

Publication Number Publication Date
HK1086562A1 true HK1086562A1 (en) 2006-09-22

Family

ID=32398347

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106518A HK1086562A1 (en) 2002-11-22 2006-06-07 Pyrazoloquinolines with immunomodulating activity

Country Status (14)

Country Link
US (2) US7081456B2 (fr)
EP (2) EP1562944B1 (fr)
JP (1) JP2006509047A (fr)
CN (1) CN100347173C (fr)
AT (1) ATE353898T1 (fr)
AU (1) AU2003279687A1 (fr)
CA (1) CA2506524A1 (fr)
DE (1) DE60311861T2 (fr)
ES (1) ES2282693T3 (fr)
HK (1) HK1086562A1 (fr)
NO (1) NO20053018L (fr)
NZ (1) NZ540081A (fr)
RU (1) RU2328496C2 (fr)
WO (1) WO2004048378A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60326639D1 (de) * 2002-12-16 2009-04-23 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
JP4892338B2 (ja) 2003-03-14 2012-03-07 メディジーン アーゲー 免疫調節複素環化合物
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
PL1776366T3 (pl) 2004-08-09 2009-06-30 Medigene Ag Immunomodulujące oksopirazolocynoliny jako inhibitory CD80
WO2008043072A2 (fr) * 2006-10-05 2008-04-10 Biogen Idec Inc. Antagonistes de cd80 pour le traitement des affections néoplasiques
EP2676666A1 (fr) * 2012-06-20 2013-12-25 Eidgenössische Technische Hochschule Zürich (ETH) Composés destinés à être utilisés dans le diagnostic ou la thérapie de plaques d'athérosclérose vulnérables
CN102977095B (zh) * 2012-12-03 2015-10-28 华东理工大学 吡唑并喹啉类化合物及其用途
BR112015014839B1 (pt) 2012-12-22 2022-09-06 Kbp Biosciences Co., Ltd Forma cristalina do composto utilizado como antagonista do receptor de mineralocorticoide, seus usos, seu processo de preparação e composição farmacêutica
EP2883883A1 (fr) 2013-12-16 2015-06-17 Cardio3 Biosciences S.A. Cibles thérapeutiques et agents utiles dans le traitement des lésions ischémiques de reperfusion
CN110698456B (zh) * 2019-11-06 2021-05-14 重庆医药高等专科学校 一种2,3-二氢硫代色烯-4-酮及其衍生物的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
PH21213A (en) * 1984-10-26 1987-08-21 Fujisawa Pharmaceutical Co Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same
US4758427A (en) * 1985-08-08 1988-07-19 Ciba-Geigy Corporation Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
AU7220991A (en) 1990-02-02 1991-08-21 Boots Company Plc, The Therapeutic agents
GB9002423D0 (en) * 1990-02-06 1990-04-04 Boots Co Plc Therapeutic agents
CN1069272A (zh) * 1991-08-02 1993-02-24 布茨公司 制备苯并吡或噻喃并吡唑的方法
ID16283A (id) * 1996-03-20 1997-09-18 Astra Pharma Prod Senyawa yang berguna dibidang farmasi
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) * 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds

Also Published As

Publication number Publication date
DE60311861D1 (de) 2007-03-29
JP2006509047A (ja) 2006-03-16
US20050203118A9 (en) 2005-09-15
US20060217411A1 (en) 2006-09-28
ATE353898T1 (de) 2007-03-15
NZ540081A (en) 2008-03-28
US7081456B2 (en) 2006-07-25
EP1813616A3 (fr) 2007-08-08
EP1813616A2 (fr) 2007-08-01
EP1562944B1 (fr) 2007-02-14
DE60311861T2 (de) 2007-11-22
CN100347173C (zh) 2007-11-07
CN1729191A (zh) 2006-02-01
US20040116461A1 (en) 2004-06-17
ES2282693T3 (es) 2007-10-16
WO2004048378A1 (fr) 2004-06-10
EP1813616B1 (fr) 2013-03-27
NO20053018D0 (no) 2005-06-20
RU2005119639A (ru) 2006-01-20
US7291612B2 (en) 2007-11-06
EP1562944A1 (fr) 2005-08-17
NO20053018L (no) 2005-08-22
CA2506524A1 (fr) 2004-06-10
RU2328496C2 (ru) 2008-07-10
AU2003279687A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
HK1086562A1 (en) Pyrazoloquinolines with immunomodulating activity
IL163629A0 (en) Glutaminyl derivatives and pharmaceutical compositions containing the same
WO2005092895A3 (fr) Composes acide propanoique beta piperidino methyle alpha aryle ou heteroaryle utilises comme antagonistes du recepteur orl1
WO2012080284A3 (fr) Composés hétérocycliques azotés 6,6-condensés substitués et leurs utilisations
RS105204A (en) Substituted 3-amino-thieno/2,3-b/pyridine- 2-carboxylic acid amide compounds and processes for preparing and their uses
PT1625126E (pt) Imidazo- e tiazolopiridinas como inibidores de cinase jak3
WO2004089366A8 (fr) Composes bicycliques comme antagonistes du recepteur nr2b
HUP0303164A2 (hu) Kinazolinok mint MMP-13 gátlók, eljárás az előállításukra, intermedierjeik és a vegyületeket tartalmazó gyógyszerkészítmények
DE602004021472D1 (en) Pyrimiidinverbindungen
PL371414A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
MX2012013130A (es) Compuestos heterociclicos de nitrogeno utiles como inhibidores de pde10.
IL181024A0 (en) Trpv1 agonists, formulations containing them and uses thereof
DK1725536T3 (da) Imidazolin-derivater med CB1-antagonistisk aktivitet
WO2004043954A3 (fr) Trans-9,10-dehydroepothilones c et d, leurs analogues et leurs procedes de production
HK1066809A1 (en) Novel immunomodulating compounds
MY129491A (en) Hydrazono-malonitriles
PE20061080A1 (es) Compuestos derivados de piridotienopirimidina como inhibidores de fosfodiesterasa 4
GB0322510D0 (en) Novel compounds
ATE425164T1 (de) Tetrazyklische immunmodulierende verbindungen
WO2006079720A8 (fr) Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
PL373468A1 (en) Oxathiincarboxamides
PL372933A1 (en) Methylthiophene carboxanilides
WO2005025492A3 (fr) Nouvelles compositions, compositions pharmaceutiques, et methodes de traitement et de prevention d'une cardiopathie

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111121